Precision Diagnostics for Alzheimer's Disease Using Patented DNA Nanotechnology

Unique Organelle Targeted Assays to Facilitate Drug Discovery for Lysosomal Storage Disorders and Numerous Neurocognitive Impairments

Old Lady
head woman.png

“Most People with Alzheimer's Disease are Never Diagnosed”

brain.png

“There is no Single Diagnostic Test for Alzheimer’s Disease.

 

Clinicians, including Neurologists, Geriatricians, and Psychiatrists, Combine Several Approaches”

We Develop Early, Precise, and Cost-Effective Diagnostic Tools for Neurodegenerative Diseases

We Combine Patented Intracellular Analytics Using DNA Nanoprobes with AI to Diagnose Before Symptoms Manifest

multiomics_edited.png

A 360-Degree Perspective for Alzheimer's Disease Based on Esya's Patented DNA Nanotechnology, Unique Biomarkers, and Our Multiomics Platform

A Paradigm shift in how Alzheimer's Disease Manifests Opens up a Whole New Way of Diagnosing, Treating and Managing the Disease

Pg_edited.jpg
Pg_edited.jpg
Pg_edited.jpg

Standalone
Diagnostic
 

For Early-Stage Alzheimer's Disease

Precision
Medicine
 

Personalized
Treatment Plans

Measurement
& Monitoring

Disease
Progression